Clinical studies consistently show substantial weight loss outcomes in patients using GLP-1 medications, often accompanied by improvements in blood sugar control, cholesterol levels, and decreased cardiovascular risks
If that sounds familiar, you're probably anxious to start losing weight
The clinical answer is that most patients lose between 2 and 5 pounds in the first four weeks, and much of that is water weight and early appetite reduction, not fat loss
Patients should only use licensed GLP-1 medications prescribed by their healthcare professional
The Bottom Line While Contrave and Wegovy reduce appetite and prompt weight loss, they reach their destination via different routes
This medical approach supports your long-term metabolic function and prioritizes your safety at every stage